Can a cholesterol drug flush out toxic PFAS from firefighters?
NCT ID NCT07226440
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether colesevelam, a drug used for high cholesterol, can reduce levels of PFAS (forever chemicals) in the blood of firefighters who have high exposure. Fifty male firefighters will take either the drug or a placebo for 12 weeks, then switch. The main goals are to see if the drug is acceptable and if it lowers PFAS levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Colesevelam (a bile acid sequestrant, also known as Welchol)
What this could lead to
If it works, this could point toward a way to reduce harmful PFAS chemicals in people with high exposure, potentially lowering long-term health risks.
What could go wrong
This is an early-phase trial with only 50 participants, so results may not apply broadly. The drug may not significantly lower PFAS levels, and side effects like stomach upset are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOXICANT EXPOSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCSF Osher Center for Integrative Health
RECRUITINGSan Francisco, California, 94115, United States
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact